IlluminOss Medical Announces the Enrollment of First Patient in EU Humerus Fracture Repair Trial
Light Fix Trial at Vienna General Hospital Will Apply IlluminOss’ Minimally Invasive, Patient-Specific Bone Stabilization Technology
East Providence, RI/Vienna, Austria (March 3, 2015) – IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that the first patient has been enrolled in its EU Light Fix trial for the treatment of impending and pathologic fractures in the humerus due to metastatic carcinoma. The trial will be led by Prof. Reinhard Windhager, MD of the University Clinic of Vienna Orthopaedic Department. Prof. Windhager is a worldleading orthopedic oncologist who heads the Department of Orthopaedic Surgery at Vienna General Hospital (AKH). The EU Light Fix trial will enroll up to 45 patients at approximately 10 centers in Austria, Germany and the Netherlands.
© 2019 Pappas Capital, LLC. ALL RIGHTS RESERVED.